Understanding the Impact of Stimulants on Sleep in ADHD: Evidence from Systematic Assessment of Sleep in Adults.
- Published in:
- CNS Drugs, 2022, v. 36, n. 3, p. 253, doi. 10.1007/s40263-022-00905-5
- By:
- Publication type:
- Article
Works matching IS 11727047 AND DT 2022 AND VI 36 AND IP 3
Results: 7
1
2
A Practical Guide to the Treatment of Dravet Syndrome with Anti-Seizure Medication.
- Published in:
- CNS Drugs, 2022, v. 36, n. 3, p. 217, doi. 10.1007/s40263-022-00898-1
- By:
- Publication type:
- Article
3
Non-parenteral Ketamine for Depression: A Practical Discussion on Addiction Potential and Recommendations for Judicious Prescribing.
- Published in:
- CNS Drugs, 2022, v. 36, n. 3, p. 239, doi. 10.1007/s40263-022-00897-2
- By:
- Publication type:
- Article
4
Population Pharmacokinetic–B Cell Modeling for Ofatumumab in Patients with Relapsing Multiple Sclerosis.
- Published in:
- CNS Drugs, 2022, v. 36, n. 3, p. 283, doi. 10.1007/s40263-021-00895-w
- By:
- Publication type:
- Article
5
Efficacy and Safety of HSK3486 for Anesthesia/Sedation in Patients Undergoing Fiberoptic Bronchoscopy: A Multicenter, Double-Blind, Propofol-Controlled, Randomized, Phase 3 Study.
- Published in:
- CNS Drugs, 2022, v. 36, n. 3, p. 301, doi. 10.1007/s40263-021-00890-1
- By:
- Publication type:
- Article
6
COMT Inhibitors in the Management of Parkinson's Disease.
- Published in:
- CNS Drugs, 2022, v. 36, n. 3, p. 261, doi. 10.1007/s40263-021-00888-9
- By:
- Publication type:
- Article
7
The Potential of KCNQ Potassium Channel Openers as Novel Antidepressants.
- Published in:
- CNS Drugs, 2022, v. 36, n. 3, p. 207, doi. 10.1007/s40263-021-00885-y
- By:
- Publication type:
- Article